Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status

Journal of the American College of Cardiology

Volumn 61, Issue 21, 2013, Pages 2130-2138

  Amin, Amit P ^a,b   Bachuwar, Alok ^a,b   Reid, Kimberly J ^c   Chhatriwalla, Adnan K ^c,d   Salisbury, Adam C ^c,d   Yeh, Robert W ^e   Kosiborod, Mikhail ^c,d   Wang, Tracy Y ^f   Alexander, Karen P ^f   Gosch, Kensey ^c   Cohen, David J ^c,d   Spertus, John A ^c,d   Bach, Richard G ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clopidogrel; dual antiplatelet therapy; EuroQOL; nuisance bleeding; quality of life

Indexed keywords

ANTITHROMBOCYTIC AGENT; THIENOPYRIDINE DERIVATIVE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING; EUROQOL 5 DIMENSION QUESTIONNAIRE; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUISANCE BLEEDING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; VISUAL ANALOG SCALE;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84877975639     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.02.044     Document Type: Article

References (31)

1. F.G. Kushner, M. Hand, S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
2. D.L. Bhatt, K.A. Fox, W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 20 2006 1706 1717 354
3. A. Squizzato, T. Keller, E. Romualdi, S. Middeldorp Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease Cochrane Database Syst Rev 19 2011 CD005158
4. S.R. Steinhubl, P.B. Berger, J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 20 2002 2411 2420 288
5. P. Widimsky, Z. Motovska, S. Simek Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 Eur Heart J 29 2008 1495 1503
6. P.G. Steg, K. Huber, F. Andreotti Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 2011 1854 1864
7. S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
8. R. Mehran, S. Pocock, E. Nikolsky Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials J Am Coll Cardiol Intv 4 2011 654 664
9. S.V. Manoukian The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk J Invasive Cardiol 22 2010 132 141
10. S.V. Manoukian Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction Am J Cardiol 104 2009 9C 15C
11. E. bu-Assi, J.M. Gracia-Acuna, I. Ferreira-Gonzalez, C. Pena-Gil, P. Gayoso-Diz, J.R. Gonzalez-Juanatey Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction Circulation 121 2010 2419 2426
12. S. Subherwal, R.G. Bach, A.Y. Chen Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
13. R. Mehran, S.V. Rao, D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
14. I. Ben-Dor, R. Torguson, M. Scheinowitz Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents Am Heart J 159 2010 871 875
15. P. Roy, L. Bonello, R. Torguson Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation Am J Cardiol 102 2008 1614 1617
16. S.V. Arnold, P.S. Chan, P.G. Jones Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry Circ Cardiovasc Qual Outcomes 4 2011 467 476
17. R. Rabin, C.F. de EQ-5D: a measure of health status from the EuroQol Group Ann Med 33 2001 337 343
18. B. Schweikert, H. Hahmann, R. Leidl Validation of the EuroQol questionnaire in cardiac rehabilitation Heart 92 2006 62 67
19. J.J. Ellis, K.A. Eagle, E.M. Kline-Rogers, S.R. Erickson Validation of the EQ-5D in patients with a history of acute coronary syndrome Curr Med Res Opin 21 2005 1209 1216
20. G. Zou A modified Poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706
21. K.A. Eagle, M.J. Lim, O.H. Dabbous A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
22. V. Dhillon, N. Hurst, J. Hannan, G. Nuki Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture Osteoporos Int 16 2005 483 489
23. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
24. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
25. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
26. R.C. Becker, J.P. Bassand, A. Budaj Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial Eur Heart J 32 2011 2933 2944
27. M. Valgimigli, G. Campo, M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
28. E. Kedhi, G.W. Stone, D. Kereiakes Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials J Am Coll Cardiol 59 2012 E321
29. J.A. Spertus, R. Kettelkamp, C. Vance Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 20 2006 2803 2809 113
30. C. Decker, L. Garavalia, B. Garavalia, J.A. Spertus Clopidogrel-taking behavior by drug-eluting stent patients: discontinuers versus continuers Patient Prefer Adherence 2 2008 167 175
31. L. Garavalia, P.M. Ho, B. Garavalia Clinician-patient discord: exploring differences in perspectives for discontinuing clopidogrel Eur J Cardiovasc Nurs 10 2011 50 55